In January, Randy Hillard was part of the U.S. Food and Drug Administration committee that considered the first application for a “biosimilar” medication. In this guest post, he describes patients’ role in the drug approval process and how the committee’s decision could influence cancer care in the future. Read More >>
treatment
June 9, 2015 · Randy Hillard, MD
June 4, 2015 · Cat Snyder, ASCO staff
In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed. Read More >>
May 5, 2015 · Cat Snyder, ASCO staff
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer. Read More >>
April 16, 2015 · Amber Bauer, ASCO staff
People with cancer often take dietary and herbal products to boost health, improve nutrition, or reduce treatment side effects. However, these products are not approved by the U.S. Food and Drug Administration like drugs and may interact with standard cancer treatments. Read More >>
April 14, 2015 · Cat Snyder, ASCO staff
First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment. Read More >>